KTTA PASITHEA THERAPEUTICS CORP

Ownership history in XTX Topco Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in PASITHEA THERAPEUTICS CORP (KTTA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 20,783 -13,575 -39.5% 0.00% $27K $1.29
2025 Q3 INITIATED 34,358 0.00% $25K $0.73
% of Fund (quarterly)    KTTA price (monthly, adj. close)
← Back to XTX Topco Ltd Holdings